Elderly Hodgkin Lymphoma Patients Treated With Chemoradiotherapy

Updated 06/21/2024

Status Active, not recruiting

Clinical Trial Summary

Outcome of Hodgkin lymphoma patients over than 60 years treated by chemotherapy and/or radiotherapy: retrospective analysis.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03535948
Study type	Observational
Source	Central Hospital, Nancy, France
Contact
Status	Active, not recruiting
Phase
Start date	May 15, 2018
Completion date	December 2019

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT04653649` - CAR T-cells Against CD30 (HSP-CAR30) for Relapsed/ Refractory Hodgkin and T-cell Lymphoma.	Phase 1/Phase 2
	Recruiting	`NCT04636255` - Physical Capacity in Hodgkin Lymphoma Survivors	N/A
	Not yet recruiting	`NCT06421987` - Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors
	Recruiting	`NCT05597761` - Immunogenicity of COVID-19 Vaccination in Autologous HSCT or CAR-T Cells Recipients
	Completed	`NCT03155425` - PD-1 Antibody SHR-1210 in Patients With Relapsed or Refractory Classic Hodgkin's Lymphoma	Phase 2
	Recruiting	`NCT03260101` - Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study
	Recruiting	`NCT04776265` - RWE of Brentuximab Vedotin Consolidation in Patients With RR HL Who Receive Salvage Chemotherapy and ASCT
	Recruiting	`NCT04378647` - BREntuximab Vedotin in SEcond LIne Therapy BEfore Transplant	Phase 2
	Recruiting	`NCT04758650` - Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions, Cardiovascular Atherosclerosis, Syndrome With Abnormal Immune Activation and sarcoïdosis	Phase 2
	Recruiting	`NCT05137886` - PD-1 Inhibitor Combined With Decitabine Followed by ASCT as Second-line Therapy for Relapsed or Refractory Classic Hodgkin's Lymphoma	Phase 2
	Recruiting	`NCT05798897` - Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma	Phase 1
	Completed	`NCT04292626` - Molecular Imaging of Lymphoma Using Labeled Technetium-99m 1-Thio-D-Glucose	Phase 1
	Active, not recruiting	`NCT04268706` - Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT)	Phase 2
	Recruiting	`NCT04638790` - First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)	Phase 3
	Completed	`NCT01578967` - Induction Chemo w/ABVD Followed by Brentuximab Vedotin Consolidation in Newly Diagnosed, Non-Bulky Stage I/II Hodgkin Lymphoma	N/A
	No longer available	`NCT03914885` - Compassionate Use Re-Infusion of ATLCAR.CD30